On June 26, HSS’ newly formed Advisory Committee on Immunization Practices voted 5-2 to recommend Merck’s respiratory syncytial virus monoclonal antibody drug and against an ingredient in some flu vaccines.The RSV drug in question, clesrovimab, is recommended for infants younger than 8 months. It was approved in early June, making it the second FDA-approved RSV […]
